Jaguar Health, Inc.
JAGX
$1.02
-$0.14-12.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.50M | -10.41M | -10.46M | -9.92M | -9.85M |
| Total Depreciation and Amortization | 557.00K | 556.00K | 546.00K | 593.00K | 596.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 2.21M | 3.04M | 1.28M | 2.94M | 3.10M |
| Change in Net Operating Assets | 2.05M | 623.00K | 1.32M | -1.44M | -178.00K |
| Cash from Operations | -4.69M | -6.19M | -7.32M | -7.83M | -6.34M |
| Capital Expenditure | -54.00K | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -215.00K | -- |
| Cash from Investing | -54.00K | -- | -- | -215.00K | 0.00 |
| Total Debt Issued | 0.00 | -3.00K | 3.45M | -- | -- |
| Total Debt Repaid | -199.00K | -145.00K | -238.00K | -171.00K | -221.00K |
| Issuance of Common Stock | 4.20M | 2.83M | 1.77M | 3.03M | 3.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.38M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -114.00K | -30.00K | -17.00K | -30.00K | -18.00K |
| Cash from Financing | 6.26M | 2.66M | 4.97M | 2.83M | 3.53M |
| Foreign Exchange rate Adjustments | -196.00K | 57.00K | 36.00K | -56.00K | 31.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.32M | -3.48M | -2.31M | -5.27M | -2.78M |